Skip to content

Comparison Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy

A Comparison of Surgical Outcomes Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02897531
Enrollment
130
Registered
2016-09-13
Start date
2016-09-30
Completion date
2020-07-31
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomosis

Keywords

Ileocolic, stapled, laparoscopy, right hemicolectomy

Brief summary

The purpose of this study is to evaluate the efficacy of end-to-side anastomosis after laparoscopic right hemicolectomy compared with that of side-to-side anastomosis. The investigators hypothesize that the end-to-side anastomosis may be associated with superior recovery compared with side-to-side anastomosis after laparoscopic right hemicolectomy under enhanced recovery program. The primary endpoint is the cumulative recovery rate, consisting of the recovery time of diet, pain, ambulation, and afebrile status.

Detailed description

All patients will be received a laparoscopic right hemicolectomy by three experienced colorectal surgeons and randomly divided into two groups according to the method of anastomosis: - the end-to-side anastomosis group and the side-to-side anastomosis group. After the surgery, enhanced recovery program will be implemented. The primary endpoint is the cumulative recovery rate according to the method of anastomosis. The cumulative recovery rate is defined as the percentage of patients who are satisfied with all aspects of recovery time, including i) tolerance of diet for 24 hours, 2) analgesic-free (oral or intravenous (IV) analgesic drugs not necessary after cessation of patient-controlled analgesia (PCA)), 3) safe ambulation (ambulation of 600m without assistance), 4) afebrile status without major complications (fever was defined as body temperature greater than 37.2°C at axilla). Secondary endpoints are postoperative hospital stay, complications, the failure rate of the enhanced recovery program, and the readmission rate within 1 month after surgery. The expected cumulative recovery rate in postoperative day 7 is 90% in the end-to-side anastomosis group and 70% in the side-to-side anastomosis group. The sample size of 130 patients was calculated as follow: Based on the assumption that cumulative recovery rate will increase to 20% using the end-to-side anastomosis, it was calculated that 65 patients should be in each group. The sample size was calculated by the formula for a power 80%, alpha error of 0.05 and dropout rate of 10%.

Interventions

PROCEDUREES anastomosis

The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.

PROCEDURESS anastomosis

The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients who have all of the following: * Age: 18 - 80 * Right-sided colon cancer (adenocarcinoma, located in cecum to hepatic flexure) * Appropriate laboratory (Bone marrow) findings (Hemoglobin ≥ 10g/dl, White blood cell count ≥ 4,000/mm3, Platelet ≥ 100,000/mm3) * Appropriate renal function (Creatinine ≤ 1.5 mg/dl) * Appropriate cardio-pulmonary functions * Appropriate understanding of the study and provide the informed consent

Exclusion criteria

Patients who have 1 or more of the following: * Distant metastasis or locally advanced tumor which required combined resection of other organs, such as the ureter, duodenum, or small bowel. * Not suitable for laparoscopic surgery * Currently taking medication for dyschezia, such as constipation or diarrhea. * Not suitable for adapting enhanced recovery program due to underlying diseases, such as cardio-pulmonary disease, mental disorder, and etc. * Not suitable for participation in this clinical trial based on the judgment of the investigators

Design outcomes

Primary

MeasureTime frameDescription
Cumulative Recovery Rateat 7 days after operationThe cumulative recovery rate is defined as the percentage of patients who are satisfied with all aspects of recovery time. Recovery time includes the following: 1. Tolerance of diet for 24hours 2. Analgesic-free status (oral or intravenous (IV) analgesic drugs not necessary after cessation of patient-controlled analgesia (PCA)), 3. Safe ambulation (ambulation of 600m without assistance), 4. Afebrile status without major complications (fever was defined as body temperature greater than 37.2°C at axilla).

Secondary

MeasureTime frameDescription
Postoperative Hospital Stayat discharge from hospital, an average of 1 weekTime(days) from operation to discharge
Postoperative Complicationsat 30 daysIncludes any minor complication (ileus, wound infection) to major complications requiring re-intervention
Failure Rate of the Enhanced Recovery Programat discharge from hospital, an average of 1 weekthe number of patients who failed to adhere to the ERAS protocol
Readmission Rate Within 1 Month After Surgeryat 30 daysthe number of patients who were re-admitted after discharge within 1 month after surgery

Countries

South Korea

Participant flow

Pre-assignment details

During the study period, 201 patients met the inclusion criteria. Excluding patients who required combined operations (n = 18), and patients who could not undergo laparoscopic surgery or an ERAS protocol due to previous medical/surgical history (n = 22), 161 patients were invited to participate in the study. Of these, 130 provided informed consent and were randomized to either the ES or the SS group (n = 65 each)

Participants by arm

ArmCount
ES Anastomosis
Stapled end-to-side anastomosis ES anastomosis: The side wall of the transverse colon will be anastomosed to the end of the distal ileum with one circular stapler, and the blind end of the transverse colon will be closed with one linear stapler.
65
SS Anastomosis
Stapled side-to-side anastomosis SS anastomosis: The side wall of the transverse colon will be anastomosed to the side wall of the distal ileum with two linear staplers.
65
Total130

Baseline characteristics

CharacteristicES AnastomosisSS AnastomosisTotal
Age, Continuous64.8 years
STANDARD_DEVIATION 10.6
59.7 years
STANDARD_DEVIATION 11.5
62.2 years
STANDARD_DEVIATION 11.1
American Society of Anesthesiology
ASA 1
18 participants22 participants40 participants
American Society of Anesthesiology
ASA 2
39 participants33 participants72 participants
American Society of Anesthesiology
ASA 3
8 participants10 participants18 participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
South Korea
65 participants65 participants130 participants
Sex: Female, Male
Female
42 Participants32 Participants74 Participants
Sex: Female, Male
Male
23 Participants33 Participants56 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 650 / 65
other
Total, other adverse events
8 / 656 / 65
serious
Total, serious adverse events
0 / 650 / 65

Outcome results

Primary

Cumulative Recovery Rate

The cumulative recovery rate is defined as the percentage of patients who are satisfied with all aspects of recovery time. Recovery time includes the following: 1. Tolerance of diet for 24hours 2. Analgesic-free status (oral or intravenous (IV) analgesic drugs not necessary after cessation of patient-controlled analgesia (PCA)), 3. Safe ambulation (ambulation of 600m without assistance), 4. Afebrile status without major complications (fever was defined as body temperature greater than 37.2°C at axilla).

Time frame: at 7 days after operation

ArmMeasureValue (NUMBER)
ES AnastomosisCumulative Recovery Rate100 percentage of participants
SS AnastomosisCumulative Recovery Rate100 percentage of participants
Secondary

Failure Rate of the Enhanced Recovery Program

the number of patients who failed to adhere to the ERAS protocol

Time frame: at discharge from hospital, an average of 1 week

ArmMeasureValue (NUMBER)
ES AnastomosisFailure Rate of the Enhanced Recovery Program7 participants
SS AnastomosisFailure Rate of the Enhanced Recovery Program5 participants
Secondary

Postoperative Complications

Includes any minor complication (ileus, wound infection) to major complications requiring re-intervention

Time frame: at 30 days

ArmMeasureValue (NUMBER)
ES AnastomosisPostoperative Complications11 events
SS AnastomosisPostoperative Complications8 events
Secondary

Postoperative Hospital Stay

Time(days) from operation to discharge

Time frame: at discharge from hospital, an average of 1 week

ArmMeasureValue (MEDIAN)
ES AnastomosisPostoperative Hospital Stay5 days
SS AnastomosisPostoperative Hospital Stay6 days
Secondary

Readmission Rate Within 1 Month After Surgery

the number of patients who were re-admitted after discharge within 1 month after surgery

Time frame: at 30 days

ArmMeasureValue (NUMBER)
ES AnastomosisReadmission Rate Within 1 Month After Surgery3 participants
SS AnastomosisReadmission Rate Within 1 Month After Surgery2 participants

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026